N/A N=30 Clinical Performance of Habitual Wearers of Avaira Toric When Refitted With Clariti Toric Lenses
Astigmatism
Primary: Visual Acuity - Enfilcon A and Somofilcon A — -0.013; -0.013; -0.010; -0.023 logMar
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=224 Treating Tobacco Dependence in Inpatient Psychiatry - 1
Tobacco Use Cessation · Tobacco Use Disorder
Primary: 7 Day Point Prevalence of Cigarette Abstinence — 3; 14; 6; 14 Participants — p=0.018
N/A N=30 Clinical Performance of Existing Wearers of Avaira Sphere Following a Refit With Clariti Elite Sphere
Myopia
Primary: Visual Acuity - Enfilcon A and Somofilcon A — -0.037; -0.037; -0.037; -0.037 logMar
Phase 4 N=132 Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: The Percentage of Subjects With Clinical Response at Week 12 Who Also Had Clinical Response at Week 52 — 69.1 percentage of subjects
N/A N=430 Family Nutrition Physical Activity Tool Use During Well Child Visits
Obesity
Primary: Percentage of Patients With Documented Goal Setting — 4.09; 71.90 percentage of participant charts
N/A N=7 Study to Investigate the Ability of [11C]Donepezil PET to Image the Parasympathetic Nervous System
Parkinson's Disease
Primary: Distribution Volume (DV) of [11C]Donepezil - BASELINE — 18.0; 22.1; 21.4; 26.6 mL
Phase 2 N=38 Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
Obsessive-compulsive Disorder · Ocd
Primary: Partial Responders by Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) — 5; 2 participants — p=.24
Phase 4 N=172 Strattice in Repair of Inguinal Hernias
Hernia, Inguinal
Primary: Change From Baseline in Activities Assessment Scale at 3 Months — -7.49; -6.12 units on a scale
Phase 3 N=42 Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin
Type 2 Diabetes Mellitus (T2DM)
Primary: Percentage of Patients Who Reported at Least One Symptomatic Hypoglycemic Event During the 24 Week Randomized Period in Both Treatment Arms — 22.2; 45.0 percent of…
N/A N=334 Effect of Suture for Mesh Fixation in Lichtenstein Hernia Repair
Inguinal Hernia
Primary: Pain, Numbness and Discomfort in the Groin — 28; 34 participants
Phase 3 N=67 Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients
Obesity · Premature Recovery From Anesthesia
Primary: Postoperative Care Unit (PACU) Recovery Time — 98.2; 95 Minutes
Phase 1 N=18 Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
Pancreatic Cancer
Primary: Number of Participants Who Experienced a Dose Limiting Toxicity to Determine the Maximum Tolerated Dose (MTD) — 0; 2; 2 participants
N/A N=36 Outlook Quality of Life Intervention
Cancer · Congestive Heart Failure · Chronic Obstructive Pulmonary Disease
Primary: Quality of Life - Preparation — 14.4; 16.0; 15.4; 15.2 units on a scale — p=.047
Phase 2 N=21 Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Neurofibromatosis 2 · Vestibular Schwannoma
Primary: Estimated Volumetric Progression Free Survival at 12 Months — 70.6 Liklihood of PFS at 12 months
N/A N=1,022 Testing the Helpfulness of 2 Decision Aids for Prostate Cancer
Prostate Cancer
Primary: Knowledge — 53; 48 percentage correct on a 12 item scale